Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic
Authors
Keywords
COVID-19 pandemic, primary hyperparathyroidism, severe hypercalcemia
Journal
CLINICAL THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-20
DOI
10.1016/j.clinthera.2021.02.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk for Infections During Treatment With Denosumab for Osteoporosis: a Systematic Review and Meta-analysis
- (2020) Talia Diker-Cohen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
- (2020) Sangeun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS—2020 UPDATE
- (2020) Pauline M. Camacho et al. Endocrine Practice
- Endocrinology in the time of COVID-19: Management of calcium disorders and osteoporosis
- (2020) Neil J Gittoes et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression
- (2020) Raymond Pranata et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19)
- (2020) Rasha A. Al-Lami et al. MAYO CLINIC PROCEEDINGS
- Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019
- (2020) Jia-Kui Sun et al. Aging-US
- Non-surgical management of primary hyperparathyroidism in the aging population
- (2020) Cristiana Cipriani et al. MATURITAS
- Exploring links between vitamin D deficiency and COVID-19
- (2020) Mradul Mohan et al. PLoS Pathogens
- Stopping Denosumab
- (2019) Olivier Lamy et al. Current Osteoporosis Reports
- Protective Effect of Denosumab on Bone in Older Women with Primary Hyperparathyroidism
- (2018) Cristina Eller-Vainicher et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Primary Hyperparathyroidism
- (2018) Karl L. Insogna NEW ENGLAND JOURNAL OF MEDICINE
- Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study
- (2017) M. B. Zanchetta et al. OSTEOPOROSIS INTERNATIONAL
- Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus
- (2016) A. A. Khan et al. OSTEOPOROSIS INTERNATIONAL
- Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery
- (2015) A. Khan et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab
- (2014) Dharshini Karuppiah et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Medical Management of Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism
- (2014) Claudio Marcocci et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism
- (2014) R. Cesareo et al. OSTEOPOROSIS INTERNATIONAL
- Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism
- (2013) Symeon Tournis et al. JOURNAL OF BONE AND MINERAL METABOLISM
- MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly
- (2012) Marcello Filopanti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism
- (2010) Emily M. Stein et al. BONE
- Skeletal Effects of Interventions in Mild Primary Hyperparathyroidism: A Meta-Analysis
- (2010) Shyam Sankaran et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cinacalcet HCl Reduces Hypercalcemia in Primary Hyperparathyroidism across a Wide Spectrum of Disease Severity
- (2010) Munro Peacock et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism
- (2009) Claudio Marcocci et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
- (2008) Paul D. Miller et al. BONE
- Hyperparathyroid Crisis: Use of Bisphosphonates as a Bridge to Parathyroidectomy
- (2008) Roy Phitayakorn et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started